ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2023

Pharmacokinetics and Safety of iGlarLixi in Healthy Chinese Participants: Results of a Phase 1 Randomized Study.

Panpan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.